PTC
JAZZ icon

Private Trust Company’s Jazz Pharmaceuticals JAZZ Stock Holding History

Private Trust Company’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$945 Hold
5
– – ﹤0.01% 2494
2025
Q4 		$850 Sell
5
-14
-74% -$2.15K ﹤0.01% 2441
2025
Q3 		$2.5K Sell
19
-9
-32% -$1.08K ﹤0.01% 2310
2025
Q2 		$2.92K Sell
28
-33
-54% -$3.58K ﹤0.01% 2196
2025
Q1 		$7.57K Buy
61
+11
+22% +$1.44K ﹤0.01% 1897
2024
Q4 		$6.16K Buy
50
+10
+25% +$1.18K ﹤0.01% 1911
2024
Q3 		$4.46K Hold
40
– – ﹤0.01% 1986
2024
Q2 		$4.27K Hold
40
– – ﹤0.01% 1983
2024
Q1 		$4.82K Sell
40
-5
-11% -$612 ﹤0.01% 1933
2023
Q4 		$5.54K Buy
45
+40
+800% +$4.99K ﹤0.01% 1883
2023
Q3 		$647 Hold
5
– – ﹤0.01% 2228
2023
Q2 		$620 Hold
5
– – ﹤0.01% 2208
2023
Q1 		$732 Hold
5
– – ﹤0.01% 2180
2022
Q4 		$1K Hold
5
– – ﹤0.01% 2102
2022
Q3 		$1K Hold
5
– – ﹤0.01% 1963
2022
Q2 		$1K Buy
+5
New +$770 ﹤0.01% 2041
2014
Q4 		– Sell
-12
Closed -$2K – 742
2014
Q3 		$2K Hold
12
– – ﹤0.01% 1597
2014
Q2 		$2K Buy
12
+6
+100% +$832 ﹤0.01% 1600
2014
Q1 		$1K Buy
+6
New +$903 ﹤0.01% 1641
2013
Q4 		– Sell
-38
Closed -$3K – 1790
2013
Q3 		$3K Sell
38
-30
-44% -$2.42K ﹤0.01% 1283
2013
Q2 		$5K Buy
+68
New +$4.16K ﹤0.01% 1070

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Private Trust Company's JAZZ Position: Q1 2026 in Review

Private Trust Company held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 5 shares worth $945. The position accounts for ﹤0.01% of the portfolio, ranked #2494.

Private Trust Company first reported a position in JAZZ in Q2 2013 and has held it in 21 quarters since. The position peaked at $7.57K in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Private Trust Company held 5 shares of Jazz Pharmaceuticals worth $945 as of Q1 2026.
  • Private Trust Company left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Private Trust Company's portfolio in Q1 2026, its #2494 holding.
  • Private Trust Company first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 21 quarters since.
  • Private Trust Company's Jazz Pharmaceuticals position peaked at $7.57K in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Private Trust Company's 13F filing for Q1 2026, filed 30 Apr 2026.